118 related articles for article (PubMed ID: 9350206)
1. Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.
Spanik S; Trupl J; Kunova A; Drgona L; Salek T; Mardiak J; Kukuckova E; Studena M; Pichna P; Oravcova E; Grey E; Koren P; Svec J; Lacka J; Sufliarsky J; Krcmery V
J Med Microbiol; 1997 Jun; 46(6):517-23. PubMed ID: 9350206
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes.
Spánik S; Krcméry V; Trupl J; Ilavská I; Hel'pianska L; Drgona L; Salek T; Mardiak J; Kukucková E; Studená M; Pichna P; Oravcová E; Grey E; Koren P; Minárik T; Lacka J; Sufliarsky J
Bratisl Lek Listy; 1996 Nov; 97(11):652-9. PubMed ID: 9117428
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Spanik S; Trupl J; Ilavska I; Helpianska L; Drgona L; Demitrovicova A; Kukuckova E; Studena M; Pichna P; Oravcova E; Rusnakova V; Koren P; Lacka J; Krcmery V
J Chemother; 1996 Oct; 8(5):387-93. PubMed ID: 8957720
[TBL] [Abstract][Full Text] [Related]
4. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Krupova Y; Novotny J; Sabo A; Mateicka F; Krcmery V
Int J Antimicrob Agents; 1998 Nov; 10(4):313-6. PubMed ID: 9916907
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 553 episodes of monomicrobial bacteraemia in cancer patients: any association between risk factors and outcome to particular pathogen?
Spanik S; Kukuckova E; Pichna P; Grausova S; Krupova I; Rusnakova V; Kralovicova K; Krchnakova A; Mrazova M; Lacka J; Koren P; Stopkova K; Nogova J; Demitrovicova A; Helpianska L; Krcmery V
Support Care Cancer; 1997 Jul; 5(4):330-3. PubMed ID: 9257432
[TBL] [Abstract][Full Text] [Related]
6. Bacteraemia in a paediatric oncology unit in South Africa.
van de Wetering MD; Poole J; Friedland I; Caron HN
Med Pediatr Oncol; 2001 Dec; 37(6):525-31. PubMed ID: 11745891
[TBL] [Abstract][Full Text] [Related]
7. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Spanik S; Trupl J; Kunova A; Botek R; Sorkovska D; Grey E; Studena M; Lacka J; Oravcova E; Krchnakova A; Rusnakova V; Svec J; Krupova I; Grausova S; Stopkova K; Koren P; Krcmery V
Scand J Infect Dis; 1997; 29(3):245-9. PubMed ID: 9255883
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia.
Kukuckova E; Spanik S; Ilavska I; Helpianska L; Oravcova E; Lacka J; Krupova I; Grausova S; Koren P; Bezakova I; Grey E; Balaz M; Studena M; Kunova A; Torfs K; Trupl J; Korec S; Stopkova K; Krcmery V
Support Care Cancer; 1996 Nov; 4(6):427-34. PubMed ID: 8961473
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K
J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164
[TBL] [Abstract][Full Text] [Related]
11. Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Krcmery V; Trup J; Kunova A; Spanik S; Drgona L; Oravcova E; Studena M; Lacka J; Sevcikova L; Koren P; Kukuckova E; Stopkova K; Krupova I; Grausova S; Svec J
Int J Clin Pharmacol Res; 1996; 16(2-3):43-9. PubMed ID: 9063755
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections in neutropenic patients with haematological malignancies.
Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
[TBL] [Abstract][Full Text] [Related]
13. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
14. Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.
Krcmery V; Spanik S; Mrazova M; Trupl J; Grausova S; Grey E; Kukuckova E; Sulcova M; Krupova I; Koren P
Int J Infect Dis; 2002 Mar; 6(1):69-73. PubMed ID: 12044306
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the management of intravascular catheter-related infections.
Mermel LA; Farr BM; Sherertz RJ; Raad II; O'Grady N; Harris JS; Craven DE;
J Intraven Nurs; 2001; 24(3):180-205. PubMed ID: 11530364
[TBL] [Abstract][Full Text] [Related]
16. Role of hydrochloric acid in the treatment of central venous catheter infections in children with cancer.
Barbaric D; Curtin J; Pearson L; Shaw PJ
Cancer; 2004 Oct; 101(8):1866-72. PubMed ID: 15386305
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in consecutive hospitalized UK patients with bacteraemia or fungaemia caused by medical devices and procedures.
Melzer M; Wickramasinghe D; Welch C
J Hosp Infect; 2015 Oct; 91(2):146-52. PubMed ID: 26275709
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Persson L; Vikerfors T; Sjöberg L; Engervall P; Tidefelt U
Scand J Infect Dis; 2000; 32(6):615-21. PubMed ID: 11200370
[TBL] [Abstract][Full Text] [Related]
19. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management.
Sutter D; Stagliano D; Braun L; Williams F; Arnold J; Ottolini M; Epstein J
Pediatr Infect Dis J; 2008 May; 27(5):400-5. PubMed ID: 18398386
[TBL] [Abstract][Full Text] [Related]
20. [Infection associated with hemodialysis and peritoneal dialysis catheters].
Fariñas MC; García-Palomo JD; Gutiérrez-Cuadra M
Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):518-26. PubMed ID: 19094867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]